<?xml version="1.0"?>
<VGCodes>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Adenovirus types 4 and 7</Value>
 <Name>CVXCode</Name>
 <Value>143       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ADENO</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>82</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>adenovirus, type 4</Value>
 <Name>CVXCode</Name>
 <Value>54        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ADENO</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>82</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>adenovirus, type 7</Value>
 <Name>CVXCode</Name>
 <Value>55        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ADENO</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>82</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>adenovirus, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>82        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ADENO</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>82</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>anthrax</Value>
 <Name>CVXCode</Name>
 <Value>24        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ANTHRAX</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>BCG</Value>
 <Name>CVXCode</Name>
 <Value>19        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>BCG</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>botulinum antitoxin</Value>
 <Name>CVXCode</Name>
 <Value>27        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>cholera</Value>
 <Name>CVXCode</Name>
 <Value>26        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>cholera</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>26</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>CMVIG</Value>
 <Name>CVXCode</Name>
 <Value>29        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>IG</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>14</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>dengue fever</Value>
 <Name>CVXCode</Name>
 <Value>56        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>diphtheria antitoxin</Value>
 <Name>CVXCode</Name>
 <Value>12        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DT (pediatric)</Value>
 <Name>CVXCode</Name>
 <Value>28        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP</Value>
 <Name>CVXCode</Name>
 <Value>20        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP, 5 pertussis antigens</Value>
 <Name>CVXCode</Name>
 <Value>106       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>107       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP,IPV,Hib,HepB</Value>
 <Name>CVXCode</Name>
 <Value>146       </Value>
 <Name>Status</Name>
 <Value>Pending</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP,IPV,Hib,HepB</Value>
 <Name>CVXCode</Name>
 <Value>146       </Value>
 <Name>Status</Name>
 <Value>Pending</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP,IPV,Hib,HepB</Value>
 <Name>CVXCode</Name>
 <Value>146       </Value>
 <Name>Status</Name>
 <Value>Pending</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP,IPV,Hib,HepB</Value>
 <Name>CVXCode</Name>
 <Value>146       </Value>
 <Name>Status</Name>
 <Value>Pending</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hep B-IPV</Value>
 <Name>CVXCode</Name>
 <Value>110       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hep B-IPV</Value>
 <Name>CVXCode</Name>
 <Value>110       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hep B-IPV</Value>
 <Name>CVXCode</Name>
 <Value>110       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hib</Value>
 <Name>CVXCode</Name>
 <Value>50        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hib</Value>
 <Name>CVXCode</Name>
 <Value>50        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hib-IPV</Value>
 <Name>CVXCode</Name>
 <Value>120       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hib-IPV</Value>
 <Name>CVXCode</Name>
 <Value>120       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hib-IPV</Value>
 <Name>CVXCode</Name>
 <Value>120       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-IPV</Value>
 <Name>CVXCode</Name>
 <Value>130       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-IPV</Value>
 <Name>CVXCode</Name>
 <Value>130       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-IPV-HIB-HEP B, historical</Value>
 <Name>CVXCode</Name>
 <Value>132       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-IPV-HIB-HEP B, historical</Value>
 <Name>CVXCode</Name>
 <Value>132       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-IPV-HIB-HEP B, historical</Value>
 <Name>CVXCode</Name>
 <Value>132       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-IPV-HIB-HEP B, historical</Value>
 <Name>CVXCode</Name>
 <Value>132       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTP</Value>
 <Name>CVXCode</Name>
 <Value>01        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTP-Hib</Value>
 <Name>CVXCode</Name>
 <Value>22        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTP-Hib</Value>
 <Name>CVXCode</Name>
 <Value>22        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTP-Hib-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>102       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTP-Hib-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>102       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTP-Hib-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>102       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>hantavirus</Value>
 <Name>CVXCode</Name>
 <Value>57        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>HBIG</Value>
 <Name>CVXCode</Name>
 <Value>30        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HBIG</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A, adult</Value>
 <Name>CVXCode</Name>
 <Value>52        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepA</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>85</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A, IG</Value>
 <Name>CVXCode</Name>
 <Value>154       </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A, ped/adol, 2 dose</Value>
 <Name>CVXCode</Name>
 <Value>83        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepA</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>85</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A, ped/adol, 3 dose</Value>
 <Name>CVXCode</Name>
 <Value>84        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepA</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>85</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A, pediatric, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>31        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepA</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>85</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>85        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepA</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>85</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>104       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepA</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>85</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>104       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep B, adolescent or pediatric</Value>
 <Name>CVXCode</Name>
 <Value>08        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep B, adolescent/high risk infant</Value>
 <Name>CVXCode</Name>
 <Value>42        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep B, adult</Value>
 <Name>CVXCode</Name>
 <Value>43        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep B, dialysis</Value>
 <Name>CVXCode</Name>
 <Value>44        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep B, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>45        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep C</Value>
 <Name>CVXCode</Name>
 <Value>58        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepC</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep E</Value>
 <Name>CVXCode</Name>
 <Value>59        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Hep E</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>herpes simplex 2</Value>
 <Name>CVXCode</Name>
 <Value>60        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib (HbOC)</Value>
 <Name>CVXCode</Name>
 <Value>47        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib (PRP-D)</Value>
 <Name>CVXCode</Name>
 <Value>46        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib (PRP-OMP)</Value>
 <Name>CVXCode</Name>
 <Value>49        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib (PRP-T)</Value>
 <Name>CVXCode</Name>
 <Value>48        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>17        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>51        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>51        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>HIV</Value>
 <Name>CVXCode</Name>
 <Value>61        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>HPV, bivalent</Value>
 <Name>CVXCode</Name>
 <Value>118       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HPV</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>HPV, quadrivalent</Value>
 <Name>CVXCode</Name>
 <Value>62        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HPV</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>HPV, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>137       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HPV</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>IG</Value>
 <Name>CVXCode</Name>
 <Value>86        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>IG</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>14</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>IG, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>14        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>IG</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>14</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>IGIV</Value>
 <Name>CVXCode</Name>
 <Value>87        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>IG</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>14</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza nasal, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>151       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, H5N1-1203</Value>
 <Name>CVXCode</Name>
 <Value>123       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>H5N1 flu</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, high dose seasonal</Value>
 <Name>CVXCode</Name>
 <Value>135       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, injectable, MDCK, preservative free</Value>
 <Name>CVXCode</Name>
 <Value>153       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, injectable, quadrivalent</Value>
 <Name>CVXCode</Name>
 <Value>158       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, injectable, quadrivalent, preservative free</Value>
 <Name>CVXCode</Name>
 <Value>150       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, live, intranasal</Value>
 <Name>CVXCode</Name>
 <Value>111       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, live, intranasal, quadrivalent</Value>
 <Name>CVXCode</Name>
 <Value>149       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, recombinant, injectable, preservative free</Value>
 <Name>CVXCode</Name>
 <Value>155       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, seasonal, injectable</Value>
 <Name>CVXCode</Name>
 <Value>141       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, seasonal, injectable, preservative free</Value>
 <Name>CVXCode</Name>
 <Value>140       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, seasonal, intradermal, preservative free</Value>
 <Name>CVXCode</Name>
 <Value>144       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, split (incl. purified surface antigen)</Value>
 <Name>CVXCode</Name>
 <Value>15        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>88        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, whole</Value>
 <Name>CVXCode</Name>
 <Value>16        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>IPV</Value>
 <Name>CVXCode</Name>
 <Value>10        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Japanese Encephalitis IM</Value>
 <Name>CVXCode</Name>
 <Value>134       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Japanese encephalitis</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Japanese encephalitis SC</Value>
 <Name>CVXCode</Name>
 <Value>39        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Japanese encephalitis</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Japanese Encephalitis, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>129       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Japanese encephalitis</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Junin virus</Value>
 <Name>CVXCode</Name>
 <Value>63        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>leishmaniasis</Value>
 <Name>CVXCode</Name>
 <Value>64        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>leprosy</Value>
 <Name>CVXCode</Name>
 <Value>65        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Lyme disease</Value>
 <Name>CVXCode</Name>
 <Value>66        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Lyme disease</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>M/R</Value>
 <Name>CVXCode</Name>
 <Value>04        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MEASLES</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>M/R</Value>
 <Name>CVXCode</Name>
 <Value>04        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RUBELLA</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>malaria</Value>
 <Name>CVXCode</Name>
 <Value>67        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>measles</Value>
 <Name>CVXCode</Name>
 <Value>05        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MEASLES</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>melanoma</Value>
 <Name>CVXCode</Name>
 <Value>68        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal C conjugate</Value>
 <Name>CVXCode</Name>
 <Value>103       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Meningococcal C/Y-HIB PRP</Value>
 <Name>CVXCode</Name>
 <Value>148       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Meningococcal C/Y-HIB PRP</Value>
 <Name>CVXCode</Name>
 <Value>148       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal MCV4, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>147       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Meningococcal MCV4O</Value>
 <Name>CVXCode</Name>
 <Value>136       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal MCV4P</Value>
 <Name>CVXCode</Name>
 <Value>114       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal MPSV4</Value>
 <Name>CVXCode</Name>
 <Value>32        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>108       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>MMR</Value>
 <Name>CVXCode</Name>
 <Value>03        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MMR</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>MMRV</Value>
 <Name>CVXCode</Name>
 <Value>94        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MMR</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>MMRV</Value>
 <Name>CVXCode</Name>
 <Value>94        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>VARICELLA</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>mumps</Value>
 <Name>CVXCode</Name>
 <Value>07        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MUMPS</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Novel influenza-H1N1-09</Value>
 <Name>CVXCode</Name>
 <Value>127       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>H1N1 flu</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>128</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Novel Influenza-H1N1-09, all formulations</Value>
 <Name>CVXCode</Name>
 <Value>128       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>H1N1 flu</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>128</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Novel Influenza-H1N1-09, nasal</Value>
 <Name>CVXCode</Name>
 <Value>125       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>H1N1 flu</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>128</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Novel influenza-H1N1-09, preservative-free</Value>
 <Name>CVXCode</Name>
 <Value>126       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>H1N1 flu</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>128</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>OPV</Value>
 <Name>CVXCode</Name>
 <Value>02        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>parainfluenza-3</Value>
 <Name>CVXCode</Name>
 <Value>69        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>pertussis</Value>
 <Name>CVXCode</Name>
 <Value>11        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>plague</Value>
 <Name>CVXCode</Name>
 <Value>23        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Pneumococcal conjugate PCV 13</Value>
 <Name>CVXCode</Name>
 <Value>133       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPCV</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>152</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>pneumococcal conjugate PCV 7</Value>
 <Name>CVXCode</Name>
 <Value>100       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPCV</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>152</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Pneumococcal Conjugate, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>152       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPCV</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>152</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>pneumococcal polysaccharide PPV23</Value>
 <Name>CVXCode</Name>
 <Value>33        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPPV</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>pneumococcal, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>109       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>polio, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>89        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Q fever</Value>
 <Name>CVXCode</Name>
 <Value>70        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rabies, intradermal injection</Value>
 <Name>CVXCode</Name>
 <Value>40        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RABIES</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>90</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rabies, intramuscular injection</Value>
 <Name>CVXCode</Name>
 <Value>18        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RABIES</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>90</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rabies, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>90        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RABIES</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>90</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rheumatic fever</Value>
 <Name>CVXCode</Name>
 <Value>72        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Rho(D) -IG IM</Value>
 <Name>CVXCode</Name>
 <Value>157       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Rho(D)-IG</Value>
 <Name>CVXCode</Name>
 <Value>156       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Rift Valley fever</Value>
 <Name>CVXCode</Name>
 <Value>73        </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>RIG</Value>
 <Name>CVXCode</Name>
 <Value>34        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>IG</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>14</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rotavirus, monovalent</Value>
 <Name>CVXCode</Name>
 <Value>119       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ROTAVIRUS</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>122</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rotavirus, pentavalent</Value>
 <Name>CVXCode</Name>
 <Value>116       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ROTAVIRUS</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>122</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rotavirus, tetravalent</Value>
 <Name>CVXCode</Name>
 <Value>74        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ROTAVIRUS</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>122</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rotavirus, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>122       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ROTAVIRUS</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>122</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>RSV-IGIV</Value>
 <Name>CVXCode</Name>
 <Value>71        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>IG</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>14</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>RSV-MAb</Value>
 <Name>CVXCode</Name>
 <Value>93        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>RSV-MAb (new)</Value>
 <Name>CVXCode</Name>
 <Value>145       </Value>
 <Name>Status</Name>
 <Value>Pending</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rubella</Value>
 <Name>CVXCode</Name>
 <Value>06        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RUBELLA</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rubella/mumps</Value>
 <Name>CVXCode</Name>
 <Value>38        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MUMPS</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rubella/mumps</Value>
 <Name>CVXCode</Name>
 <Value>38        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RUBELLA</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Staphylococcus bacterio lysate</Value>
 <Name>CVXCode</Name>
 <Value>76        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Td (adult)</Value>
 <Name>CVXCode</Name>
 <Value>138       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Td</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>139</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Td (adult) preservative free</Value>
 <Name>CVXCode</Name>
 <Value>113       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Td</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>139</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Td (adult), adsorbed</Value>
 <Name>CVXCode</Name>
 <Value>09        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Td</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>139</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Td(adult) unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>139       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Td</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>139</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Tdap</Value>
 <Name>CVXCode</Name>
 <Value>115       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Td</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>139</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>tetanus toxoid, adsorbed</Value>
 <Name>CVXCode</Name>
 <Value>35        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>tetanus toxoid, not adsorbed</Value>
 <Name>CVXCode</Name>
 <Value>142       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>tetanus toxoid, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>112       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>tick-borne encephalitis</Value>
 <Name>CVXCode</Name>
 <Value>77        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>TIG</Value>
 <Name>CVXCode</Name>
 <Value>13        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>TST, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>98        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>TST-OT tine test</Value>
 <Name>CVXCode</Name>
 <Value>95        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>TST-PPD intradermal</Value>
 <Name>CVXCode</Name>
 <Value>96        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>TST-PPD tine test</Value>
 <Name>CVXCode</Name>
 <Value>97        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>tularemia vaccine</Value>
 <Name>CVXCode</Name>
 <Value>78        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>typhoid, oral</Value>
 <Name>CVXCode</Name>
 <Value>25        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>TYPHOID</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>91</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>typhoid, parenteral</Value>
 <Name>CVXCode</Name>
 <Value>41        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>TYPHOID</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>91</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>typhoid, parenteral, AKD (U.S. military)</Value>
 <Name>CVXCode</Name>
 <Value>53        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>TYPHOID</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>91</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>typhoid, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>91        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>TYPHOID</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>91</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>typhoid, ViCPs</Value>
 <Name>CVXCode</Name>
 <Value>101       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>TYPHOID</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>91</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>typhus, historical</Value>
 <Name>CVXCode</Name>
 <Value>131       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>vaccinia (smallpox)</Value>
 <Name>CVXCode</Name>
 <Value>75        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>VACCINIA</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>vaccinia (smallpox) diluted</Value>
 <Name>CVXCode</Name>
 <Value>105       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>VACCINIA</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>vaccinia immune globulin</Value>
 <Name>CVXCode</Name>
 <Value>79        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>varicella</Value>
 <Name>CVXCode</Name>
 <Value>21        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>VARICELLA</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>VEE, inactivated</Value>
 <Name>CVXCode</Name>
 <Value>81        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>VEE</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>92</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>VEE, live</Value>
 <Name>CVXCode</Name>
 <Value>80        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>VEE</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>92</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>VEE, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>92        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>VEE</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value>92</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>VZIG</Value>
 <Name>CVXCode</Name>
 <Value>36        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>VZIG (IND)</Value>
 <Name>CVXCode</Name>
 <Value>117       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value></Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>yellow fever</Value>
 <Name>CVXCode</Name>
 <Value>37        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>YELLOWFEVER</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>zoster</Value>
 <Name>CVXCode</Name>
 <Value>121       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ZOSTER</Value>
 <Name>Uncertain formulation CVX</Name>
 <Value></Value>
 </CVXVGInfo>
</VGCodes>
